Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




LGC Standards Opens First Chinese Office

By LabMedica International staff writers
Posted on 29 Apr 2009
LGC Standards (Teddington, UK) has opened its first office in Beijing, China, signaling a milestone in the company's international development. More...
The new office will enable the company to bring its range of laboratory quality products and services to the Chinese market.

LGC Standards provides a range of products and services for measurement and laboratory control through the quick and efficient supply of reference materials and proficiency testing schemes. The company will be able to support Chinese laboratories directly by offering logistical and technical advice in their local language.

Dr Matthias Brommer, director, LGC Standards said: "The opening of our first Chinese office clearly demonstrates that LGC Standards is committed to providing global quality management solutions for laboratories worldwide. Our Chinese team will focus on supplying laboratories in the pharmaceutical, environmental, food, industrial, and forensic sectors with reference materials and proficiency testing schemes to support laboratory quality."

In welcoming LGC China to the Group, David Richardson, Chief Executive of LGC, commented, "Our new office provides an excellent opportunity for LGC to serve the Chinese scientific community and gives us a base from which to partner with local businesses on future projects. Our investment strengthens LGC's position as an international leader in reference materials.”

The company supplies over 20,000 reference materials, pharmaceutic impurity reference standards, proficiency testing and training in analytical quality. LGC Standards has offices in France, Germany, Italy, Poland, Spain, Sweden, China, and the UK, a joint venture presence in India, and representatives in Bulgaria, Czech Republic, Finland, Hungary, Ireland, Romania, Turkey, and the United States.

LGC is an international science-based company and market leader in diagnostic, analytical, and forensic services and reference standards. A progressive and innovative enterprise, LGC operates in socially responsible fields underpinning the safety, health, and security of the public and the regulation of industry, for U.K. government departments, and blue chip clients.

Related Links:

LGC Standards




Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.